help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 20, 2005
Endocrinology, doi:10.1210/en.2004-1428
A more recent version of this article appeared on May 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
146/5/2265    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Devost, D.
Right arrow Articles by Zingg, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Devost, D.
Right arrow Articles by Zingg, H. H.

Submitted on November 1, 2004
Accepted on January 12, 2005

Oxytocin Induces Dephosphorylation of Elongation Factor 2 in Human Myometrial Cells

Dominic Devost, Milena Girotti, Marie-Eve Carrier, Caterina Russo, and Hans H. Zingg*

Departments of Medicine, Pharmacology and Therapeutics, and Obstetrics and Gynecology, McGill University, Montreal, H3A 1A1

* To whom correspondence should be addressed. E-mail: hans.zingg{at}mcgill.ca.

The oxytocin receptor (OTR) mediates a wide spectrum of biological actions and is expressed in a large number of different tissues, including uterine, breast and lung tumors. To define more completely the intracellular signaling mechanisms linked to OTR activation, we have used a phospho-proteomics approach and have characterized changes in the phosphorylation states of intracellular proteins in response to OTR activation in OTR-expressing cell lines. Using a specific anti-phosphothreonine antibody, we observed several distinct changes in the threonine-phosphorylation patterns. The most prominent change involved dephosphorylation of a 95kD moiety. Purification by ion exchange chromatography combined with 1- and 2-dimensional PAGE followed by N terminal micro-sequence analysis revealed that the 95kD moiety corresponded to eukaryotic elongation factor 2 (eEF2). This protein is a key regulator of cellular protein synthesis and mediates, upon dephosphorylation, the translocation step of peptide chain elongation. Dose-response curves in myometrial cells expressing the endogenous OTR indicated a significant effect of OT on eEF2 dephosphorylation at 1 nM, a concentration close to the Kd of OT. Time course analysis indicates that the effect is rapid with a significant effect occurring at 5 min. To determine directly the effect of OT on protein synthesis, the incorporation of [35S]Met into total protein was assessed. In myometrial cells, OTR activation led to significant 29% increase in total protein synthesis over a 2 h period. These findings establish a novel link between OTR activation and cellular protein synthesis and thus define a mechanism by which OT assumes a so far unrecognized, physiologically relevant trophic function.


Key words: Oxytocin • oxytocin receptor • protein synthesis • eukaryotic Elongation Factor2 (eEF2)




This article has been cited by other articles:


Home page
EndocrinologyHome page
D. Devost, M.-E. Carrier, and H. H. Zingg
Oxytocin-Induced Activation of Eukaryotic Elongation Factor 2 in Myometrial Cells Is Mediated by Protein Kinase C
Endocrinology, January 1, 2008; 149(1): 131 - 138.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society